Skip to content

Cefazolin plasma levels and pharmacokinetic parameters during adult cardiac surgery: after implementation of a new protocol for antibiotic prophylaxis.

Cefazolin plasma levels and pharmacokinetic parameters during adult cardiac surgery: after implementation of a new protocol for antibiotic prophylaxis. - CefCheck

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48705
Enrollment
40
Registered
2019-02-21
Start date
2019-03-11
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery open hart operation

Interventions

New guideline for peri- and postoperative antibiotic prophylaxes: withholding dose at start CPB, postoperative dose at 8 and 16 hours from 1 gram cefazoline

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Informed consent Age >18 year Cardiac surgery with the use of CPB Use of cefazolin as antibiotic prophylaxis BMI

Exclusion criteria

Exclusion criteria: No informed consent Age 40 Active infection treated with antibiotics before surgery Kidney function impairment, defined as eGFR 3 times normal values.

Design outcomes

Primary

MeasureTime frame
Time and concentration of cefazolin above the MIC of 2 mg/L.

Secondary

MeasureTime frame
* PK parameters on cefazolin in patients undergoing cardiac surgery Incidence of DSWI and concomitant use of antibiotics will be recorded in the database. We will not include incidence of DSWI as an secondary objective, since this is a rare complication and the study design in not suited to investigate this. Data on kidney and liver impairment (as defined in exclusion criteria) post-operatively will also be recorded in the database.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)